Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06255210 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)

Study acronym: ESICON
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to learn about the induction chemotherapy efficacy in olfactory neuroblastoma. The main question it aims to answer is: wether olfactory neuroblastoma patients with different pathology subtypes apply to different induction chemotherapy schemes. Participants will be treated with different chemotherapy schemes, to evaluate the tumor remission rate and long term survival.
Trial Details
NCT Number NCT06255210
Lead Sponsor Hongmeng Yu
Conditions
(from sponsor)		 Olfactory Neuroblastoma
Related terms Esthesioneuroblastoma, Olfactory
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov